Swiss Soliris® and Ultomiris® Reimbursement Registry SSURR: An observational registry for capturing data of patients suffering from paroxysmal nocturnal hemoglobinuria (PNH) who are treated with Soliris® (eculizumab) or Ultomiris® (ravulizumab) First published 22/09/2020 Last updated 27/03/2024 EU PAS number:EUPAS37218 Study Ongoing